Home >> msds >> Adriamycin

Adriamycin

Print        Favorite
[Fire Fighting]

Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
[Ingestion]

Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended.
[Inhalation]

If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention.
[Skin]

Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician should examine the area if irritation or pain persists.
[Eyes]

Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.
[Storage]

Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
[Handling]

Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
[Inhalation]

Causes respiratory tract irritation. May cause allergic respiratory tract irritation. Can produce delayed pulmonary edema.
[Skin]

Doxorubicin has irritant properties. Severe ulceration and necrosis may occur from extravasation.
[Eyes]

Causes eye irritation. May cause chemical conjunctivitis.
[Ingestion]

Nausea, vomiting, and diarrhea may occur.
[Personal Protection]

Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
[Respirators]

Respiratory protection should be an adjunct to and not a substitute for engineering controls.<BR>Organic vapor acid gas canister; done in the open, an area away from drafts and traffic
[Exposure Effects]

Prolonged or repeated exposure may cause adverse reproductive effects. Repeated exposure may cause allergic respiratory reaction (asthma). Effects may be delayed. May cause allergic skin reaction in some individuals.
[Appearance]

Orange powder.
[Solubility in water]

2%
[Melting Point]

216
[pKa/pKb]

8.33 (pKa)
[Usage]

Medication.
[Product Name]

(1S,3S)-3,5,12-Trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
[Synonyms]

(85-Cis)-10-Tetrahydro-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-methoxy-5,12-Naphthacenedione
(8S)-10-((4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
ADM
Adriamycin
Adriblastin
Adriblastina
[CAS]

"CASEN_23214-92-8.htm">23214-92-8
[Formula]

C27H29NO11
[Molecular Weight]

543.53
[EINECS]

245-495-6
[RTECS]

AV9800000
[RTECS Class]

Tumorigen; Drug; Mutagen; Reproductive Effector; Human Data; Natural Product; Primary Irritant
[Merck]

12,3495
[Beilstein/Gmelin]

1445811
[Small spills/leaks]

Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately. Avoid generating dusty conditions. Provide ventilation.
[Stability]

Stable at room temperature in closed containers under normal storage and handling conditions.
[Incompatibilities]

Strong oxidizing agents.
[Decomposition]

Hydrogen chloride, nitrogen oxides, carbon monoxide, carbon dioxide.